Saha-CATH2

General Information


DRACP ID  DRACP00621

Peptide Name   Saha-CATH2

Sequence  TFKRKNGSRKNGHRPGGYSLIALGNKKVLKAPYMESI

Sequence Length  37

UniProt ID  Not available

PubChem CID  Not available

Origin  Sarcophilus harrisii

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma Not active up to 500µg/ml Alamar blue assay 24h 1

Hemolytic Activity  Human erythrocytes:5% Hemolysis=1-500µg/ml

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00621

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C183H303N57O49S

Absent amino acids  CDQW

Common amino acids  K

Mass  476012

Pl  11.43

Basic residues  10

Acidic residues  1

Hydrophobic residues  9

Net charge  9

Boman Index  -8021

Hydrophobicity  -86.76

Aliphatic Index  65.95

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  2980

Absorbance 280nm  82.78

Polar residues  14

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 27725697

Title  Cathelicidins in the Tasmanian devil (Sarcophilus harrisii)

Doi 10.1038/srep35019

Year  2016

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.